AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliclavac M 40mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Prevego Healthcare & Research Private Limited

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Gliclavac M 40mg/500mg Tablet

Diabetic patients using Gliclavac M 40mg/500mg tablets, a dual-action anti-diabetic medication, should adhere to their prescribed dosage. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage adjustments may be necessary based on individual blood sugar monitoring and your physician's assessment. Continuous use, even with controlled blood sugar, is crucial. Premature discontinuation, without medical consultation, risks elevated blood glucose, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is a cornerstone of a comprehensive diabetes management plan that encompasses a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counter hypoglycemia, and maintain regular mealtimes. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. This medication's suitability during pregnancy or lactation requires medical consultation. Regular blood glucose monitoring is essential, along with periodic blood tests to assess hematologic parameters and liver function.

Uses of Gliclavac M 40mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Gliclavac M 40mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or break it. Consume Gliclavac M 40mg/500mg Tablet with a meal.

Common Side effects of Gliclavac M 40mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclavac M 40mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliclavac M 40mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Gliclavac M 40mg/500mg Tablet works:

Gliclazide and Metformin, combined as Gliclavac M 40mg/500mg tablets, offer dual action for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Gliclavac M 40mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Gliclavac M 40mg/500mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gliclavac M 40mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliclavac M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Gliclavac M 40mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclavac M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease may begin with a reduced dose; however, its use is contraindicated in those with severe liver dysfunction. Medical advice is essential.

What if you forget to take Gliclavac M 40mg/500mg Tablet :

Should you forget to take a Gliclavac M 40mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliclavac M 40mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Gliclavac M 40mg/500mg Tablet

Gliclavac M 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control, supplementing a healthy diet and exercise regimen. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Gliclavac M 40mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclavac M 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclavac M 40mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Gliclavac M 40mg/500mg Tablets and seek immediate medical attention.
Prolonged Gliclavac M 40mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclavac M 40mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gliclavac M 40mg/500mg tablets with alcohol is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Gliclavac M 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Gliclavac M 40mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclavac M 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Gliclavac M 40mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who do not consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclavac M 40mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Gliclavac M 40mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Gliclavac M 40mg/500mg Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gliclavac M 40mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar and raise the risk of lactic acidosis.
Gliclavac M 40mg/500mg Ta...
56
MRP 68
17% off